MA28485B1 - Formulations de solutions pharmaceutiques stables pour aerosols-doseurs pressurises - Google Patents

Formulations de solutions pharmaceutiques stables pour aerosols-doseurs pressurises

Info

Publication number
MA28485B1
MA28485B1 MA29342A MA29342A MA28485B1 MA 28485 B1 MA28485 B1 MA 28485B1 MA 29342 A MA29342 A MA 29342A MA 29342 A MA29342 A MA 29342A MA 28485 B1 MA28485 B1 MA 28485B1
Authority
MA
Morocco
Prior art keywords
dosers
formulations
stable pharmaceutical
pharmaceutical solutions
pressurized aerosols
Prior art date
Application number
MA29342A
Other languages
English (en)
Inventor
David Lewis
David Ganderton
Brian Meakin
Maurizio Delcanale
Fausto Pivetti
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP04011424A external-priority patent/EP1595531A1/fr
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of MA28485B1 publication Critical patent/MA28485B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4704—2-Quinolinones, e.g. carbostyril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D83/00—Containers or packages with special means for dispensing contents
    • B65D83/14—Containers for dispensing liquid or semi-liquid contents by internal gaseous pressure, i.e. aerosol containers comprising propellant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/009—Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Dispersion Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Mechanical Engineering (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MA29342A 2004-02-27 2006-09-22 Formulations de solutions pharmaceutiques stables pour aerosols-doseurs pressurises MA28485B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US54779804P 2004-02-27 2004-02-27
EP04011424A EP1595531A1 (fr) 2004-05-13 2004-05-13 Formulation d'une solution pharmaceutique stable pour aérosols doseurs sous pression

Publications (1)

Publication Number Publication Date
MA28485B1 true MA28485B1 (fr) 2007-03-01

Family

ID=34921308

Family Applications (1)

Application Number Title Priority Date Filing Date
MA29342A MA28485B1 (fr) 2004-02-27 2006-09-22 Formulations de solutions pharmaceutiques stables pour aerosols-doseurs pressurises

Country Status (5)

Country Link
US (1) US20070025920A1 (fr)
KR (1) KR20070000476A (fr)
IL (1) IL177103A0 (fr)
MA (1) MA28485B1 (fr)
NO (1) NO20064359L (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0510852A (pt) * 2004-05-13 2007-11-27 Chiesi Farma Spa produtos medicinais em formulação aerossol com estabilidade quìmica aprimorada
US8227027B2 (en) * 2007-12-07 2012-07-24 Presspart Gmbh & Co. Kg Method for applying a polymer coating to an internal surface of a container
US8532271B2 (en) * 2009-01-21 2013-09-10 Chung-Yu Lin Cybercrime detecting and preventing method and system established by telephone number code, authorization codes and source identification code

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8334494D0 (en) * 1983-12-24 1984-02-01 Tanabe Seiyaku Co Carbostyril derivatives
ATE177941T1 (de) * 1992-12-09 1999-04-15 Boehringer Ingelheim Pharma Stabilisierte medizinische aerosollösungen
HU219900B (hu) * 1995-04-14 2001-09-28 Glaxo Wellcome Inc. Mért dózist adagoló inhalálóberendezés
HU219899B (hu) * 1995-04-14 2001-09-28 Glaxo Wellcome Inc. Inhalálóberendezés flutikaszon-propionát adagolására mért dózisban
ES2234266T3 (es) * 1998-07-24 2005-06-16 Jago Research Ag Formulaciones medicas para aerosoles.
DE19847969A1 (de) * 1998-10-17 2000-04-20 Boehringer Ingelheim Pharma Lagerfähig flüssige Formulierung mit Formoterol
IT1303788B1 (it) * 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
DZ2947A1 (fr) * 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
AU2000250701B2 (en) * 2000-05-22 2004-07-01 Chiesi Farmaceutici S.P.A. Stable pharmaceutical solution formulations for pressurised metered dose inhalers
ES2342463T3 (es) * 2002-03-01 2010-07-07 Chiesi Farmaceutici S.P.A. Formulacion superfina de formoterol.
EP1340492A1 (fr) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Formulations d'aérosol pour l'administration par voie pulmonaire de medicaments avec effet systémique
EP1595531A1 (fr) * 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Formulation d'une solution pharmaceutique stable pour aérosols doseurs sous pression

Also Published As

Publication number Publication date
HK1103280A1 (zh) 2007-12-14
US20070025920A1 (en) 2007-02-01
KR20070000476A (ko) 2007-01-02
NO20064359L (no) 2006-09-26
IL177103A0 (en) 2006-12-10

Similar Documents

Publication Publication Date Title
MA28489B1 (fr) Preparations pharmaceutiques
ITBO20050123A1 (it) Formulazioni farmaceutiche gastroresistenti contenenti rifaximina
TWI366460B (en) Cannabinoid active pharmaceutical ingredient for improved dosage forms
NO20075628L (no) Farmasøytiske formuleringer
EP1773768A4 (fr) Derives de pyrrole en tant qu'agents pharmaceutiques
EP2224973A4 (fr) Conservateurs pour compositions cosmétiques, de toilette et pharmaceutiques
EP2131848A4 (fr) Compositions et methodes de potentialisation de l'activite de molecules biologiquement actives
EP1981547A4 (fr) Formulations therapeutiques stables
EP1973595A4 (fr) Catheter actif pour biodetection et intervention chirurgicale
IL187957A0 (en) Liquid pharmaceutical formulations of docetaxel
EP2124556A4 (fr) Compositions pharmaceutiques
FR2873585B1 (fr) Nouvelles formulations galeniques de principes actifs
SK4325U (sk) Farmaceutická kompozícia s postupným uvoľňovaním
IL187916A0 (en) Tablet containing hardly soluble active ingredient
FR2915683B1 (fr) Formulations pharmaceutiques auto-precipitantes pour la liberation modifiee de principe actif
IL180031A0 (en) Stable pharmaceutical formulations of benzimidazole compounds
EP1762216A4 (fr) Composition pour préparation cosmétique et préparation cosmétique
EP1830831A4 (fr) Formulations pharmaceutiques contenant des sels de gallium
MX2007013327A (es) Formulaciones de liberacion prolongada.
PL1655026T3 (pl) Zawierające diacereinę i meloksikam stałe preparaty farmaceutyczne
MA28485B1 (fr) Formulations de solutions pharmaceutiques stables pour aerosols-doseurs pressurises
DK1798234T3 (da) Farmaceutisk sammensætning omfattende temozolomidester
EP1857093A4 (fr) Preparation cosmetique pour la peau
EP1837026A4 (fr) Agent therapeutique pour la fonction hepatique
IS7290A (is) Lyfjasamsetningar sem innihalda risperidone